Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse events. Data from the Evaluation of Platelets IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial

De Servi, S.

Italian Heart Journal. Supplement Official Journal of the Italian Federation of Cardiology 2(7): 805-806

2001


ISSN/ISBN: 1129-4728
PMID: 11508303
Document Number: 526887

Document emailed within 1 workday
Secure & encrypted payments